NO972608L - Opplösningshjelpemidler for hydrofile makromolekyler - Google Patents

Opplösningshjelpemidler for hydrofile makromolekyler

Info

Publication number
NO972608L
NO972608L NO972608A NO972608A NO972608L NO 972608 L NO972608 L NO 972608L NO 972608 A NO972608 A NO 972608A NO 972608 A NO972608 A NO 972608A NO 972608 L NO972608 L NO 972608L
Authority
NO
Norway
Prior art keywords
hydrophilic macromolecules
dissolving aids
preparation
compound
hydrophilic
Prior art date
Application number
NO972608A
Other languages
English (en)
Other versions
NO972608D0 (no
Inventor
Roger Randal Charles New
Christopher John Kirby
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO972608D0 publication Critical patent/NO972608D0/no
Publication of NO972608L publication Critical patent/NO972608L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lift Valve (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

En fremgangsmåte for fremstilling av et enkeltfaset, hydrofobt preparat omfattende en hydrofil forbindelse i et hydrofobt oppløsningsmiddel, hvori en forbindelse som er: (a) en lavmolekylær forbindelse med minst noen grad av polaritet; og/eller (b) en lipid- oppløselig organisk syre; og/eller (c) en amfifil forbindelse; og (d) glyserol eller andre polyvalente alkoholer; tilsettes under fremgangsmåten som et opp- løsningshjelpemiddel.
NO972608A 1994-12-09 1997-06-06 Opplösningshjelpemidler for hydrofile makromolekyler NO972608L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9424902.6A GB9424902D0 (en) 1994-12-09 1994-12-09 Solubilisation Aids
PCT/GB1995/002891 WO1996017593A1 (en) 1994-12-09 1995-12-08 Solubilisation aids for hydrophilic macromolecules

Publications (2)

Publication Number Publication Date
NO972608D0 NO972608D0 (no) 1997-06-06
NO972608L true NO972608L (no) 1997-08-08

Family

ID=10765694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972608A NO972608L (no) 1994-12-09 1997-06-06 Opplösningshjelpemidler for hydrofile makromolekyler

Country Status (14)

Country Link
US (1) US5968549A (no)
EP (1) EP0796085B1 (no)
JP (1) JPH10510256A (no)
CN (1) CN1169113A (no)
AT (1) ATE192920T1 (no)
AU (1) AU4122496A (no)
CA (1) CA2207279A1 (no)
DE (1) DE69517048T2 (no)
FI (1) FI972442A0 (no)
GB (1) GB9424902D0 (no)
IL (1) IL116313A0 (no)
NO (1) NO972608L (no)
WO (1) WO1996017593A1 (no)
ZA (1) ZA9510508B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9521806D0 (en) * 1995-10-25 1996-01-03 Cortecs Ltd Preservation methods
TWI240627B (en) 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
AU6046098A (en) * 1997-02-07 1998-08-26 Cultor Oyj (Corporation) Process of enhancing growth and survival of aquatic organisms through water borne enrichment with stable vitamin c derivatives
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
EP1137431A1 (en) * 1998-12-04 2001-10-04 Provalis UK Limited Pharmaceutical compositions containing insulin
US7169889B1 (en) * 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US20070207138A1 (en) * 2004-03-31 2007-09-06 Aspion Co., Ltd. S/O Type Pharmaceutical Preparation and Method for Producing the Same
ES2967961T3 (es) 2004-05-03 2024-05-06 Ipsen Biopharm Ltd Liposomas útiles en la administración de fármacos
UA103758C2 (ru) 2004-07-19 2013-11-25 Биокон Лимитед Конъюгаты олигомеров инсулина, их композиции и применение
EP1785131A4 (en) * 2004-08-31 2009-03-11 Aspion Co Ltd EXTERNAL PREPARATION OF TYPE S / O
US20070104780A1 (en) * 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
BR122021024957B1 (pt) 2015-10-16 2023-12-12 Ipsen Biopharm Ltd Processos de produção de uma composição de irinotecano lipossômico estabilizado em armazenamento
KR102067094B1 (ko) * 2018-04-17 2020-01-15 김철환 비(非)계면활성제형 오일-물(o/w) 분산 조성물, 비(非)계면활성제형 물-오일(w/o) 분산 조성물 및 이들의 제조방법
CN110215740B (zh) * 2019-07-15 2021-05-04 大连医科大学 一种两性离子亲水前处理硅胶材料的制备方法
CN111888475B (zh) * 2020-07-24 2022-01-07 华中科技大学 缓控释制剂及制法与制备原位肿瘤免疫联合治疗药物应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
IL116313A0 (en) 1996-03-31
WO1996017593A1 (en) 1996-06-13
DE69517048T2 (de) 2000-09-14
EP0796085A1 (en) 1997-09-24
JPH10510256A (ja) 1998-10-06
FI972442A (fi) 1997-06-09
GB9424902D0 (en) 1995-02-08
ATE192920T1 (de) 2000-06-15
AU4122496A (en) 1996-06-26
ZA9510508B (en) 1997-06-11
CA2207279A1 (en) 1996-06-13
DE69517048D1 (de) 2000-06-21
FI972442A0 (fi) 1997-06-09
CN1169113A (zh) 1997-12-31
EP0796085B1 (en) 2000-05-17
US5968549A (en) 1999-10-19
MX9704274A (es) 1997-09-30
NO972608D0 (no) 1997-06-06

Similar Documents

Publication Publication Date Title
NO972608D0 (no) Opplösningshjelpemidler for hydrofile makromolekyler
DE3679128D1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
DE69519667D1 (de) Verfahren zur stabilisierung von duocarmycinderivaten
BR9916894A (pt) ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
DK297483D0 (da) Fremgangsmade til fremstilling af derivater af 9-(2-hydroxyethoxymethyl) guanin
BR0207776A (pt) Derivado de esterol, lipossomos compreendendo o mesmo, método de carga dos referidos lipossomos e uso dos mesmos
DE69835366D1 (de) Verfahren zur herstellung von perfluorvinylethersulfonsäure-derivaten
DE60119283D1 (de) Verfahren zur herstellung von 3-hydroxypicolinsäure-derivaten
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
DK0497816T3 (da) Behandling af HIV-infektioner og forbindelser anvendelige derved
DE69531793D1 (de) Immunogene zubereitungen
NO981864L (no) Oppl°sningsmetoder
DE69906849D1 (de) Verfahren zur Herstellung von optisch aktiven Phenylpropionsäure-Derivat
ATE183188T1 (de) Cephalosporinderivative und verfahren zu ihrer herstellung
AU4101589A (en) Pharmaceutical preparations which can be applied transdermally, containing sterolins and/or spiroketalins
DE69920568D1 (de) Verfahren zur Herstellung von optisch aktivem 4-Halo-3-hydroxybuttersäureester
YU49113B (sh) Postupak za dobijanje klavulanat soli
NO20016297L (no) Ny fremgangsmåte for rensing av aldehydurenheter
DE69813053D1 (de) Verfahren zur Herstellung von optisch aktiven Azetidin-2-Carbonsäurederivaten
AU5014285A (en) Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv)
BR0114884A (pt) Compostos calcilìticos
DE60204014D1 (de) Chlormethylierung von thiophene
GR930100408A (el) Μέ?οδος απομόνωσης και κα?αρισμού μεβινολίνης.
ATE53001T1 (de) Verfahren zur herstellung von optisch aktiven hydrochinonderivaten, sowie von d-alphatocopherol.